HOWL Q3 2022 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOWLWerewolf Therapeutics, Inc.

$41M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M

Gross Profit

$4M85.8% margin

Operating Income

-$13M-252.3% margin

Net Income

-$12M-240.3% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

+19.8%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$16M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$172M

Total Liabilities

$41M

Stockholders' Equity

$131M

Cash & Equivalents

$140M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$0	—
Gross Profit	$4M	$0	—
Operating Income	-$13M	-$14M	+9.1%
Net Income	-$12M	-$14M	+13.2%